Strona główna

  • Banner

  • Reduced price
Hodgkins & T-Cell Lymphoma: Diagnosis, Treatment Options & Prognosis

Hodgkins & T-Cell Lymphoma: Diagnosis, Treatment Options & Prognosis

9781622574780
900,84 zł
810,75 zł Save 90,09 zł Tax included
Lowest price within 30 days before promotion: 810,75 zł
Quantity
Available in 4-6 weeks

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DHL, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Description
In this book, the authors present current research in the study of the diagnosis, treatments options and prognosis of both Hodgkins and T-Cell lymphomas, gathered from across the globe. Topics discussed include the pathology and pathogenesis of Hodgkins lymphoma; total skin electron beam therapy in the treatment of cutaneous T-Cell lymphoma; HIV-associated T-Cell lymphoma; critical mass hypothesis of T-Cell responses and its application in the treatment of T-Cell lymphoma; combined modality therapy, the short term benefits and long term toxicities in Hodgkins lymphoma; and enteropathy-associated T-Cell lymphoma diagnosis and risk-stratification.
Product Details
Nova Science Publishers Inc
73987
9781622574780
9781622574780

Data sheet

Rok wydania
2013
Numer wydania
1
Oprawa
twarda
Liczba stron
179
Wymiary (mm)
180.00 x 260.00
Waga (g)
488
  • Preface; Pathology & Pathogenesis of Hodgkins Lymphoma:: Analysis of its Status over a Period of Five Decades; Treating Cutaneous T-Cell Lymphoma:: Total Skin Electron Beam Therapy; Hodgkins Lymphoma:: Past & Present Issues; Hodgkins Lymphoma:: Pathogenesis, Diagnosis, Treatment Options & Prognosis; HIV-Associated T-Cell Lymphoma:: Epidemiology, Pathobiology, Clinical Features, Prognosis & Management; Critical Mass Hypothesis of T-Cell Responses & its Application for the Treatment of T-Cell Lymphoma; Combined Modality Therapy in Hodgkin Lymphoma:: Short Term Benefits & Long Term Toxicities- Is there Evidence to De-Escalate Therapy?
Comments (0)

  • Frequently purchased together

    No products available